Search

Your search keyword '"Hadaschik, Eva"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Hadaschik, Eva" Remove constraint Author: "Hadaschik, Eva"
489 results on '"Hadaschik, Eva"'

Search Results

1. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas

2. Early versus late response to PD-1-based immunotherapy in metastatic melanoma

4. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

6. Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis

7. Characterisation and outcome of RAC1 mutated melanoma

8. Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

10. S1‐Leitlinie Talgdrüsenkarzinom

12. Immunoglobulin M pemphigoid

14. Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus

16. S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.

17. S1‐Guideline Sebaceous Carcinoma.

18. Einsatz künstlicher Intelligenz mittels Deep Learning in der dermatopathologischen Routinediagnostik des Basalzellkarzinoms

19. Deep learning based histological classification of adnex tumors

20. Applying an artificial intelligence deep learning approach to routine dermatopathological diagnosis of basal cell carcinoma

23. Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre

24. Data from HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance

25. Supplementary Figure S6 from HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance

27. NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice

28. HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance

30. Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma

32. Clinical and pathological characteristics of familial melanoma with germline <scp> TERT </scp> promoter variants

33. The impact of the COVID ‐19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres

34. Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1

35. S2k‐Leitlinie zur Diagnostik und Therapie des Schleimhautpemphigoids

36. Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features

37. S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid

39. Leg ulcers in morphea plaques

43. Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

44. Clinical and pathological characteristics of familial melanoma with germlineTERTpromoter variants

46. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors

Catalog

Books, media, physical & digital resources